Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8639765
Reference Type
Journal Article
Subtype
Review
Title
Metabolism and pharmacokinetics of resveratrol and pterostilbene
Author(s)
Wang, P; Sang, SM
Year
2018
Is Peer Reviewed?
Yes
Journal
BioFactors
ISSN:
0951-6433
EISSN:
1872-8081
Volume
44
Issue
1
Page Numbers
16-25
Language
English
PMID
29315886
DOI
10.1002/biof.1410
Web of Science Id
WOS:000424097600002
URL
http://
://WOS:000424097600002
Exit
Abstract
Beneficial properties of resveratrol and pterostilbene, a dimethyl ether analog of resveratrol, have attracted increasing interest in recent years. Resveratrol and pterostilbene exhibit many pharmacological similarities and both of them are generally considered to be safe for human consumption. Beyond the structural and general bioactivity similarities between them, large amounts of data are now available to reveal the metabolic fate and pharmacological differences between them. Pterostilbene was found to be more metabolically stable and usually exhibited stronger pharmacological activities than that of resveratrol. As a contribution to clarify and compare aspects like metabolic stability and pharmacokinetics of resveratrol and pterostilbene, as well as explain the pharmacological similarities and differences between them, this review presents and compares recent data on the metabolism and pharmacokinetics of resveratrol and pterostilbene. © 2018 BioFactors, 44(1):16-25, 2018.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity